Latin America Allergy Diagnostics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Latin America Allergy Diagnostics Market Analysis

According to the WHO (World Health Organization), nearly 80% of the world's population lives in cities, and as a result, air quality has a substantial impact on them, mainly in low-income nations. In addition, multiple studies have linked air pollution to allergic rhinitis, asthma, and other disorders, leading to an increase in allergy diagnoses. Although allergies can affect practically every organ in the body and can be triggered by a variety of external causes, there are a few common themes that should be highlighted in research efforts. Effective prevention, curative therapy, and accurate, early diagnosis, as with many other chronic diseases, are key unmet requirements. In order to organize or re-categorize clinical symptoms into more coherent, consistent, and treatment-responsive groupings, detailed phenotyping/endotyping is widely required.

Latin America Allergy Diagnostics Market Size

Latin America allergy diagnostics market size was valued at USD 5.80 billion in 2024 and is projected to reach USD 13.26 billion by 2032, with a CAGR of 10.90% during the forecast period of 2025 to 2032.

Report Scope and Market Segmentation       

Allergy Diagnostics Market Definition

Allergies affect nearly every organ in the body in a variety of ways, with a wide range of symptoms, and hence their manifestations span a vast range of phenotypes. According to studies in Europe, up to 30% of the population suffers from allergic rhino conjunctivitis, 20% suffer from asthma, and 15% suffer from allergic skin diseases. Food allergies are growing more common and severe; occupational allergies, medication allergies, and insect sting allergies (which can be lethal) contribute to the allergy epidemic.

Allergy Diagnostics Market Dynamics

Drivers

• Increasing environmental pollution levels

Exposure to indoor and outdoor air pollution, allergies, and occupational exposure are the key risk factors for chronic respiratory illnesses. The prevalence of allergy diseases is higher in city dwellers than in rural people due to the higher exposure to environmental contaminants in cities (as a result of vehicular pollution and industrial activities). More than 80% of people living in cities are exposed to air quality levels that exceed WHO safety recommendations, according to the WHO; while this is a global trend, the implications are particularly severe in low-income countries' urban zones. This is a key indicator of the market's expansion in allergy diagnostics.

• Growing environmental pollution levels

The primary drivers of growth are rising healthcare expenditures and average lifespans, increased understanding of preventative testing, improved diagnostic test offerings, rising lifestyle-related diseases, and government-mandated healthcare treatments.

• Increase in the access to health insurance

The market is dominated by large hospitals and diagnostic laboratories, which can afford high-volume systems due to their large capital budgets. Rising healthcare expenditures aid the expansion of the allergy diagnostics market as a result of high healthcare service costs. In addition, governments in many countries are giving reimbursements and healthcare insurance programmes to boost consumer demand for allergy diagnostics around the world.

Opportunities

• Use of mHealth in allergy diagnosis

With only a few mHealth tools for allergic rhinitis (AR) diagnosis published in peer-reviewed papers, the use of mHealth for rhinitis diagnosis is currently limited. A new breed of point-of-care devices has emerged as a result of recent advancements in integrated biosensors, wireless connectivity, and power harvesting techniques. AR, on the other hand, is a highly prevalent disease. Any diagnostic gadget connected to a smartphone (e.g., peak nasal inspiratory flow metres or intranasal biosensors) would have to be affordable.

Restraints/Challenges

• Difficulty in allergy diagnosis

The difficulty in allergy diagnosis is coming up with procedures that are objective, quick, repeatable, cost-effective, sensitive, and specific to the condition. They must be able to recognise exposures and contribute to therapeutic decision-making, preferably in primary care. In addition, tests to monitor therapy response and to compare preclinical and clinical effects across large cohorts and between nations are required.

• Premium costs associated with allergy diagnostic instruments

Market participants update several allergy diagnostic devices, including as luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers, on a regular basis. These instruments are more expensive since they have more advanced features and functions (the price of each instrument varies based on its accuracy, flexibility, and TAT). Immunoassay analyzers, for example, cost between USD 10,000 and USD 20,000, while luminometers cost between USD 3,000 and USD 14,000. ELISA readers that are semi-automated cost between USD 2,000 and USD 5,000, while fully automated analyzers cost over USD 14,000. In addition, operating this equipment necessitates extra costs such as maintenance and insurance, laboratory supervision, and overheads (such as utilities, space, and administration).

This Latin America allergy diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Latin America allergy diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Allergy Diagnostics Market Scope

The Latin America allergy diagnostics market is segmented on the basis of product, allergan, test, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Assay Kits
• Consumables
• Instruments
• Immunoassay Analyzers
• ELISA Analyzers
• Luminometers
• Other Instruments
• Services

Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Test

• In Vivo Tests
• Skin Prick Tests
• Patch Tests
• Other In Vivo Tests
• In Vitro Tests

End User

• Diagnostic Laboratories
• Hospital-based Laboratories
• Academic Research Institutes
• Other End Users

Distribution Channel

•  Direct
•  Indirect

Allergy Diagnostics Market Regional Analysis

The Latin America allergy diagnostics market is analyzed and market size insights and trends are provided by country, product, allergan, test, end-user and distribution channel as referenced above.

The countries covered in the Latin America allergy diagnostics market report are Brazil, Argentina and Rest of South America as part of South America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Allergy Diagnostics Market Share

The Latin America allergy diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Latin America allergy diagnostics market.

Allergy Diagnostics Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc., (US)
• Siemens Healthcare GmbH (Germany)
• Danaher (US)
• Omega Diagnostics Group PLC (UK)
• bioMérieux (France)
• Romer Labs Division Holding (Austria)
• EUROIMMUN Medizinische Labordiagnostika AG (Germany)
• HollisterStier Allergy (US)
• NEOGEN Corporation (US)
• Eurofins Scientific (Luxembourg)
• Minaris Medical America, Inc. (US)
• Stallergenes Greer (UK)
• HOB Biotech Group Corp., Ltd. (China)
• HYCOR Biomedical (US)
• R-Biopharm AG (Germany)
• AESKU.GROUP GmbH (Germany)
• ACON Laboratories, Inc. (US)
• Lincoln Diagnostics, Inc. (US)
• Astra Biotech GmbH (Germany)
• Erba Group (UK)

Latest Developments in Allergy Diagnostics Market

• In 2021, Hitachi Chemical Diagnostics, Inc. has been replaced by Minaris Medical America, Inc. By uniting the medical business group firms under the Minaris Medical brand, Hitachi wants to boost its global position and increase commercial activities in the field of in-vitro diagnostics. Both companies are owned by Showa Denko Materials Co., Ltd.
• In 2021, PerkinElmer Inc. has reached an agreement to purchase Immunodiagnostic Systems Holdings PLC. PerkinElmer Inc. will be able to strengthen its position in the ImmunoDiagnostics (IDS) industry as a result of the acquisition. EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a firm that sells allergy products and services, will take over IDS.

SKU-50718